Our Mission & Programs

People living with Hidradenitis Suppurativa are at the heart of our mission

Disseminate the latest HS knowledge for professionals and patients

Our programs directed toward both patients and medical professionals are capped by an annual international conference, the Symposium on Hidradenitis Suppurativa Advances, where the latest breakthroughs in the cause, diagnosis, control, and cure of Hidradenitis Suppurativa are shared in a three-day educational conference. Educational resources on our website include the latest treatment guidelines, online courses addressing the unmet needs of patients, and the research changing the landscape in Hidradenitis Suppurativa.

Annual Symposium on Hidradenitis Suppurativa Advances
North American Treatment Guidelines
Information on causes and treatments for patients

Guide, fund, and promote research directed by the unmet needs of patients

Hidradenitis Suppurativa is one of the most devastating diseases in all of dermatology. Research into the cause, control, and eventual cure of HS is central to our mission. We fund basic, translational, and treatment-based research through our Danby Research Grants while guiding and promoting research from relevant stakeholders.

HSF Danby Research Grants
Guide and Promote Patient-Centered Research

Advocate with All Stakeholders

Our advocacy goals strive toward more and better treatment options, easier access to care and better coverage from insurance, and patient-centered outcomes in research and drug development

Advocate for patients with payers and policy makers
Investigate Patient-Reported endpoints in clinical trials

North American Treatment Guidelines

The first evidence-based clinical management guidelines for Hidradenitis Suppurativa patients in North America

HSF Danby Research Grants

Basic, translational, and treatment-centered research directed by the unmet needs of patients

Hidradenitis Suppurativa is a disease which has a tremendous impact on the quality of life of a patient. In fact, it is considered to be one of the most severe conditions in dermatology. Thus it is our duty to drive support for research that will someday lead to a cure. Research is hope for our HS patients so please join our community in advancing our movement toward a cure.
Iltefat Hamzavi, MD
President, Hidradenitis Suppurativa Foundation
Back to Top